10.22
·Reported
·Importance II
·Sources 1
·China
According to a report by the UK's Financial Times on October 22, the liquidators of China Evergrande sent a demand letter to Harvard University, asking for the return of $2 million from a 2020 research grant, and the two sides are in negotiations. The liquidation report disclosed that Evergrande also paid the university about $156 million in 2013 and 2016, and the liquidators said they found no clear commercial rationale for these payments.
10.22
·Reported
·Importance II
·Sources 1
·China
On October 22, in the imaging-reading assessment of The Exciting Offer 8, medical student Li Ziqi answered with a blind guess of craniopharyngioma. Her clinical experience and the promotion of her record of ten SCI papers were called into question, and the topic trended online.
2024.09.23
·Verified
·Importance IV
·Sources 1
·Beijing
Around September 23, 2024, biologist Rao Yi published “Facts Trump Emotion: Wang Zhenyi, Chen Zhu, Chen Saijuan’s Research and Zhu Yuejun” on his WeChat public account, carrying out a professional verification of the historical literature and timeline. Rao Yi pointed out that the core breakthrough of all-trans retinoic acid-induced differentiation therapy for leukemia predates Zhu Yuejun’s doctoral studies, so there was no plagiarism; Zhu Yuejun’s research foundation was at the doctoral level, and his failure to obtain a degree was the combined result of academic disputes, difficulties in interpersonal communication, and the evaluation mechanisms of the time. He called on the public to view this historical tragedy rationally rather than engaging in an emotional witch hunt.
2024.09.20
·Verified
·Importance IV
·Sources 1
·湖南省邵阳市武冈市
On September 20, 2024, facing rumors continuing to swirl online about his "results being plagiarized and suppressed," Zhu Yuejun accepted a public interview to clarify the facts. He stated explicitly that his results had not been stolen, and that his failure to graduate back then was due to disagreements with his supervisor over research approaches that he refused to compromise on, rather than deliberate suppression by his supervisor; he said he had been unlucky but did not regret it, and that he had always been full of admiration for the pioneering contributions to medicine made by senior scholars such as Academician Wang Zhenyi.
2024.09
·Verified
·Importance IV
·Sources 2
·湖南省邵阳市武冈市
In mid-September 2024, as Academician Wang Zhenyi was awarded the "Medal of the Republic," videos from self-media outlets visiting Zhu Yuejun, who practices medicine in poverty in rural Wugang, Hunan, went viral on platforms like Douyin and Weibo. The stark contrast between his past role as the first author of a top-tier leukemia paper and his current status as a village doctor living on social security caused a sensation online, rapidly evolving into a public opinion storm regarding "stolen achievements and academic lords suppressing those from humble backgrounds."
2015
·Reported
·Importance IV
·Sources 3
·Wuhan
In 2015, Shi Zhengli of the Wuhan Institute of Virology took part in a study that synthesized a chimeric SARS-like coronavirus to understand its ability to infect humans; the hybrid virus described in the paper carried the spike protein of a Chinese horseshoe bat coronavirus.
1992.04
·Verified
·Importance IV
·Sources 1
·Shanghai
In April 1992, Zhu Yuejun, as first author, published the academic paper "Molecular Markers of Acute Promyelocytic Leukemia and Their Significance in the Study of Cell Differentiation" in the National Medical Journal of China, with Wang Zhenyi, Chen Zhu, Chen Saijuan and others as co-authors. The paper systematically discussed molecular genetic markers and mechanisms of cell differentiation under all-trans retinoic acid-induced differentiation therapy.
1991.11
·Verified
·Importance IV
·Sources 1
·Shanghai
In November 1991, the team at the Shanghai Institute of Hematology published important research findings in Blood, an international top-tier hematology journal, on acute promyelocytic leukemia (APL) retinoic acid receptor (RARA) rearrangement and molecular markers. Chen Saijuan was the first author, Zhu Yuejun the second author, and Wang Zhenyi, Chen Zhu and others were co-authors.